Загрузка...
1ISG-008 Economic impact of the use of biosimilar infliximab in a second-level hospital
BACKGROUND: The high price of biological drugs has become progressively unsustainable to the national health system. The development of biosimilar drugs might represent an option in reducing healthcare costs. PURPOSE: To analyse the economic impact of incorporating biosimilar infliximab (BI) in a se...
Сохранить в:
| Опубликовано в: : | Eur J Hosp Pharm |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMJ Group
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535246/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.8 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|